Paper30153293
Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.
Li H and 19 others. PLoS One, 2018. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques. Papers, record 30153293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30153293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Products, env | Major topic |
| Gene Products, gag | Major topic |
| Peptide Hydrolases | Major topic |
| Proteolysis | Major topic |
| SAIDS Vaccines | Major topic |
| Simian Immunodeficiency Virus | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Antibodies, Viral | |
| Binding Sites | |
| Cross Reactions | |
| Female | |
| Immunization | |
| Macaca fascicularis |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| C06 RR015459 | NCRR NIH HHS | United States | C06RR015459 | PubMed and NIH | NIH RePORTER |
| C06 RR020141 | NCRR NIH HHS | United States | C06RR020141 | PubMed and NIH | NIH RePORTER |
| P51 OD011106 | NIH HHS | United States | P51OD011106 | PubMed and NIH | NIH RePORTER |
| R01 AI111805 | NIAID NIH HHS | United States | R01AI111805 | PubMed and NIH | NIH RePORTER |
| Canadian Institutes of Health Research | International | PubMed | PubMed |
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9358557 | Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. | Pharm Res | 1997 | https://conductscience.org/library/papers/9358557 | PubMed |
| 2 | 28748659 | Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection. | J Med Primatol | 2017 | https://conductscience.org/library/papers/28748659 | PubMed |
| 3 | 23614052 | A polymer/oil based nanovaccine as a single-dose immunization approach. | PLoS One | 2013 | https://conductscience.org/library/papers/23614052 | PubMed |
| 4 | 17898737 | HIV vaccine failure prompts Merck to halt trial. | Nature | 2007 | https://conductscience.org/library/papers/17898737 | PubMed |
| 5 | 25591175 | Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus. | Virology | 2015 | https://conductscience.org/library/papers/25591175 | PubMed |
| 6 | 23664989 | Immunogenicity of sequences around HIV-1 protease cleavage sites: potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sites. | Vaccine | 2013 | https://conductscience.org/library/papers/23664989 | PubMed |
| 7 | 28725225 | Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design. | Front Immunol | 2017 | https://conductscience.org/library/papers/28725225 | PubMed |
| 8 | 28422786 | Antibody-mediated immune exclusion of HIV. | Curr Opin HIV AIDS | 2017 | https://conductscience.org/library/papers/28422786 | PubMed |
| 9 | 12915557 | Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness? | J Virol | 2003 | https://conductscience.org/library/papers/12915557 | PubMed |
| 10 | 20634666 | Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype. | AIDS | 2010 | https://conductscience.org/library/papers/20634666 | PubMed |
| 11 | 19534569 | Virus maturation as a new HIV-1 therapeutic target. | Expert Opin Ther Targets | 2009 | https://conductscience.org/library/papers/19534569 | PubMed |
| 12 | 23364441 | Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers. | AIDS | 2013 | https://conductscience.org/library/papers/23364441 | PubMed |
| 13 | 22072744 | For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection. | J Virol | 2012 | https://conductscience.org/library/papers/22072744 | PubMed |
| 14 | 28893268 | A novel HIV vaccine targeting the protease cleavage sites. | AIDS Res Ther | 2017 | https://conductscience.org/library/papers/28893268 | PubMed |
| 15 | 28893288 | Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design. | AIDS Res Ther | 2017 | https://conductscience.org/library/papers/28893288 | PubMed |
| 16 | 8510215 | Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. | J Virol | 1993 | https://conductscience.org/library/papers/8510215 | PubMed |
| 17 | 11739694 | ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. | J Virol | 2002 | https://conductscience.org/library/papers/11739694 | PubMed |
| 18 | 24813074 | HIV vaccines: a brief overview. | Scand J Immunol | 2014 | https://conductscience.org/library/papers/24813074 | PubMed |
| 19 | 25009956 | Recent progress in HIV vaccines inducing mucosal immune responses. | AIDS | 2014 | https://conductscience.org/library/papers/25009956 | PubMed |
| 20 | 9680484 | The role of structure in antibody cross-reactivity between peptides and folded proteins. | J Mol Biol | 1998 | https://conductscience.org/library/papers/9680484 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41902278 | Viral Escape from a Candidate HIV-1 Vaccine Targeting Protease Cleavage Sites Is Associated with a Dramatic Fitness Loss in SIVmac239-Infected Cynomolgus Macaques. | Viruses | 2026 | https://conductscience.org/library/papers/41902278 | PubMed |
| 38979723 | A long-term stable cold-chain-friendly HIV mRNA vaccine encoding multi-epitope viral protease cleavage site immunogens inducing immunogen-specific protective T cell immunity. | Emerg Microbes Infect | 2024 | https://conductscience.org/library/papers/38979723 | PubMed |
| 37337294 | Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods. | Virol J | 2023 | https://conductscience.org/library/papers/37337294 | PubMed |
| 35592073 | Toll-like Interleukin -1 Receptor Regulator (TILRR) Protein, a Major Modulator of Inflammation, is Expressed in Normal Human and Macaque Tissues and PBMCs. | J Inflamm Res | 2022 | https://conductscience.org/library/papers/35592073 | PubMed |
| 32983121 | Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens. | Front Immunol | 2020 | https://conductscience.org/library/papers/32983121 | PubMed |
| 32853182 | Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32853182 | PubMed |
| 31523362 | Antiretroviral drug-S for a possible HIV elimination. | Int J Physiol Pathophysiol Pharmacol | 2019 | https://conductscience.org/library/papers/31523362 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| INHCAP | 100129696 | PubTator's text mining | https://conductscience.org/library/genes/100129696 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30153293
GET https://conductscience.org/api/papers/v1/30153293/references?page=2